The DOI matches its Crossref record; 404 of the 409 references it cites were found in a registry or an index.
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
Abstract
G protein-coupled dopamine receptors (D1, D2, D3, D4, and D5) mediate all of the physiological functions of the catecholaminergic neurotransmitter dopamine, ranging from voluntary movement and reward to hormonal regulation and hypertension. Pharmacological agents targeting dopaminergic neurotransmission have been clinically used in the management of several neurological and psychiatric disorders, including Parkinson's disease, schizophrenia, bipolar disorder, Huntington's disease, attention deficit hyperactivity disorder (ADHD(1)), and Tourette's syndrome. Numerous advances have occurred in understanding the general structural, biochemical, and functional properties of dopamine receptors that have led to the development of multiple pharmacologically active compounds that directly target dopamine receptors, such as antiparkinson drugs and antipsychotics. Recent progress in understanding the complex biology of dopamine receptor-related signal transduction mechanisms has revealed that, in addition to their primary action on cAMP-mediated signaling, dopamine receptors can act through diverse signaling mechanisms that involve alternative G protein coupling or through G protein-independent mechanisms via interactions with ion channels or proteins that are characteristically implicated in receptor desensitization, such as β-arrestins. One of the future directions in managing dopamine-related pathologic conditions may involve a transition from the approaches that directly affect receptor function to a precise targeting of postreceptor intracellular signaling modalities either directly or through ligand-biased signaling pharmacology. In this comprehensive review, we discuss dopamine receptor classification, their basic structural and genetic organization, their distribution and functions in the brain and the periphery, and their regulation and signal transduction mechanisms. In addition, we discuss the abnormalities of dopamine receptor expression, function, and signaling that are documented in human disorders and the current pharmacology and emerging trends in the development of novel therapeutic agents that act at dopamine receptors and/or on related signaling events.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“with five dopamine receptors (D1-5), three norepinephrine receptors each with three subtypes (α1a,b,d, α2a,b,c and β1,2,3) and seven serotonin receptor families (5-HT1-7) comprised of 14 total receptors all of which are G-protein coupled, except for 5-HT3”
From Mechanisms of ketamine and its metabolites as antidepressants (2022) · cites this paper as Beaulieu & Gainetdinov, 2011
Citations
Cites
Koob, G. F., & Volkow, N. D. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.110 · Cited by 5,340
Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
Cross, D. A. E., Alessi, D. R., Cohen, P., Andjelkovich, M., & Hemmings, B. A. (1995) · Nature · doi:10.1038/378785a0 · Cited by 5,244
Dahlstroem, A., & Fuxé, K. (1964) · PubMed · Cited by 5,133
Multiple receptors for dopamine
Kebabian, J. W., & Calne, D. B. (1979) · Nature · doi:10.1038/277093a0 · Cited by 3,756
Dopamine receptors: from structure to function
MISSALE, C., NASH, S. R., ROBINSON, S. W., JABER, M., & CARON, M. G. (1998) · Physiological Reviews · doi:10.1152/physrev.1998.78.1.189 · Cited by 3,633
Pierce, K. L., Premont, R. T., & Lefkowitz, R. J. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm908 · Cited by 2,712
NEURAL MECHANISMS OF ADDICTION: The Role of Reward-Related Learning and Memory
Hyman, S. E., Malenka, R. C., & Nestler, E. J. (2006) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.29.051605.113009 · Cited by 2,647
Sokoloff, P., Bruno Giros, A., Martres, M., Bouthenet, M.-L., & Schwartz, J. (1990) · Nature · doi:10.1038/347146a0 · Cited by 2,608
Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter
Giros, B., Jaber, M., Jones, S. R., Wightman, R. M., & Caron, M. G. (1996) · Nature · doi:10.1038/379606a0 · Cited by 2,476
Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs
Creese, I., Burt, D. R., & Snyder, S. H. (1976) · Science · doi:10.1126/science.3854 · Cited by 2,220
Cited by
Sorted by citations
Items 801–900 of 1,006
Morin, N., Jourdain, V. A., Morissette, M., Grégoire, L., & Paolo, T. D. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.01.014 · Cited by 31
Li, N., Wang, H., Thia, L., Wang, J., & Wang, X. (2014) · The Analyst · doi:10.1039/c4an01900h · Cited by 31
Meade, J. A., Free, R. B., Miller, N., Chun, L. S., Doyle, T. B., Moritz, A. E., Conroy, J., Watts, V. J., & Sibley, D. R. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3726-8 · Cited by 31
Shanks, R. A., Ross, J. M., Doyle, H. H., Helton, A., Picou, B. D., Schulz, J., Tavares, C., Bryant, S., Dawson, B. L., & Lloyd, S. A. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.12.002 · Cited by 31
Pharmacological analysis of dopamine modulation in theDrosophila melanogasterlarval heart
Titlow, J., Rufer, J. M., King, K. E., & Cooper, R. L. (2013) · Physiological Reports · doi:10.1002/phy2.20 · Cited by 31
Chen, Y., Semenova, S. A., Rozov, S. V., Sundvik, M., Bonkowsky, J. L., & Panula, P. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.697466 · Cited by 31
Shahani, N., Swarnkar, S., Giovinazzo, V., Morgenweck, J., Bohn, L., Scharager-Tapia, C., Pascal, B. D., Martínez-Acedo, P., Khare, K., & Subramaniam, S. (2016) · Science Signaling · doi:10.1126/scisignal.aaf6670 · Cited by 31
Nagatomo, K., Suga, S., Saitoh, M., Kogawa, M., Kobayashi, K., Yamamoto, Y., & Yamada, K. (2017) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2017.00003 · Cited by 31
Alterations and interactions of subcortical modulatory systems in Alzheimer's disease
Leko, M. B., Hof, P. R., & Šimić, G. (2021) · Progress in brain research · doi:10.1016/bs.pbr.2020.07.016 · Cited by 31
Changing the Cortical Conductor’s Tempo: Neuromodulation of the Claustrum
Wong, K. L. L., Nair, A., & Augustine, G. J. (2021) · Frontiers in Neural Circuits · doi:10.3389/fncir.2021.658228 · Cited by 31
Neural underpinnings of fine motor skills under stress and anxiety: A review
Martins, L. A., Schiavo, A., Paz, L. V., Xavier, L. L., & Mestriner, R. G. (2024) · Physiology & Behavior · doi:10.1016/j.physbeh.2024.114593 · Cited by 30
Yang, J., Wu, Y., Lv, X., Liu, S., Yuan, Z., Chen, Y., Ding, X., Zhong, L., & Wang, X. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02413-8 · Cited by 30
Zhao, L., Lin, Y., Lao, G., Wang, Y., Guan, L., Wei, J., Yang, Z., Ni, P., Li, X., Jiang, Z., et al. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.08.039 · Cited by 30
Dazzled by the dominions of dopamine: clinical roles of D3, D2, and D1 receptors
Stahl, S. M. (2017) · CNS Spectrums · doi:10.1017/s1092852917000426 · Cited by 30
Association of genetic ancestry with striatal dopamine D2/D3 receptor availability
Wiers, C. E., Towb, P., Hodgkinson, C. A., Shen, P.-H., Freeman, C. R., Miller, G., Lindgren, E., Kojori, E. S., Demiral, Ş. B., Kim, S. W., et al. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.208 · Cited by 30
Bello, F. D., Bonifazi, A., Giorgioni, G., Cifani, C., Bonaventura, M. V. M. D., Petrelli, R., Piergentili, A., Fontana, S., Mammoli, V., Yano, H., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00265 · Cited by 30
Selective D2 receptor PET in manganese-exposed workers
Criswell, S. R., Warden, M. N., Nielsen, S. S., Perlmutter, J. S., Moerlein, S. M., Sheppard, L. A., Lenox-Krug, J., Checkoway, H., & Racette, B. A. (2018) · Neurology · doi:10.1212/wnl.0000000000006163 · Cited by 30
Current and emerging pharmaceutical interventions for myopia
Vutipongsatorn, K., Yokoi, T., & Ohno‐Matsui, K. (2019) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2018-313798 · Cited by 30
Bradley, E. C., Cunningham, R. L., Wilde, C., Morgan, R. K., Klug, E. A., Letcher, S. M., Schöneberg, T., Monk, K. R., Liebscher, I., & Petersen, S. C. (2019) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14233 · Cited by 30
Rachamalla, M., Salahinejad, A., Khan, M., Datusalia, A. K., & Niyogi, S. (2023) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2023.163771 · Cited by 30
Gür, S., & Sikka, S. C. (2015) · Andrology · doi:10.1111/andr.12032 · Cited by 30
Prion Protein Modulates Monoaminergic Systems and Depressive-like Behavior in Mice
Beckman, D., Santos, L. E., Americo, T. A., Ledo, J. H., Mello, F. G. D., & Linden, R. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.666156 · Cited by 30
Modulation of A2a receptor antagonist on D2 receptor internalization and ERK phosphorylation
Huang, L., Wu, D., Zhang, L., & Feng, L. (2013) · Acta Pharmacologica Sinica · doi:10.1038/aps.2013.87 · Cited by 30
Daws, S. E., & Konradi, C. L. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.10.004 · Cited by 30
Chronic cocaine disrupts mesocortical learning mechanisms
Buchta, W. C., & Riegel, A. C. (2015) · Brain Research · doi:10.1016/j.brainres.2015.02.003 · Cited by 30
Discovery, Optimization, and Characterization of Novel D2 Dopamine Receptor Selective Antagonists
Xiao, J., Free, R. B., Barnaeva, E. S., Conroy, J., Doyle, T. B., Miller, B. N., Bryant-Genevier, M. G., Taylor, M. K., Hu, X., Dulcey, A. E., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500126s · Cited by 30
Ávila, C. L. M., Limón-Pacheco, J. H., Giòrdano, M., & Rodríguez, V. M. (2016) · Journal of Toxicology · doi:10.1155/2016/4763434 · Cited by 30
Vázquez-Borrego, M. C., Gahete, M. D., Martínez‐Fuentes, A. J., Fuentes-Fayos, A. C., Castano, J. P., Kineman, R. D., & Luque, R. M. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.12.007 · Cited by 30
Radiobromine and radioiodine for medical applications
Wilbur, D. S., & Adam, M. J. (2019) · Radiochimica Acta · doi:10.1515/ract-2019-0004 · Cited by 30
Yu-Taeger, L., Ott, T., Bonsi, P., Tomczak, C., Wassouf, Z., Martella, G., Sciamanna, G., Imbriani, P., Ponterio, G., Tassone, A., et al. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104634 · Cited by 30
Schumacher, F., Chakraborty, S., Kleuser, B., Gulbins, E., Schwerdtle, T., Aschner, M., & Bornhorst, J. (2015) · Talanta · doi:10.1016/j.talanta.2015.05.057 · Cited by 30
Dissociable control of motivation and reinforcement by distinct ventral striatal dopamine receptors
Enríquez-Traba, J., Arenivar, M. A., Yarur, H. E., Noh, C., Flores, R. J., Weil, T. A., Roy, S., Usdin, T. B., LaGamma, C. T., Wang, H., et al. (2024) · Nature Neuroscience · doi:10.1038/s41593-024-01819-9 · Cited by 31
Impact of neuroinflammation on brain glutamate and dopamine signalling in schizophrenia: an update
Nayak, U. Y., Manikkath, J., Arora, D. S., & Mudgal, J. (2025) · Metabolic Brain Disease · doi:10.1007/s11011-025-01548-3 · Cited by 29
Yamada, K., TAKAHASHI, S. Y., Karube, F., Fujiyama, F., Kobayashi, K., Nishi, A., & Momiyama, T. (2016) · The Journal of Physiological Sciences · doi:10.1007/s12576-016-0445-4 · Cited by 29
Genetic deletion of the dopamine D3 receptor increases vulnerability to heroin in mice
Zhan, J., Jordan, C. J., Bi, G., He, X., Gardner, E. L., Wang, Y., & Xi, Z. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.08.016 · Cited by 29
Dexmedetomidine Ameliorates Sleep Deprivation-Induced Depressive Behaviors in Mice
Moon, E.-J., Ko, I., Kim, S., Jin, J., Hwang, L., Kim, C., An, H., Lee, B.-J., & Yi, J.-W. (2018) · International Neurourology Journal · doi:10.5213/inj.1836228.114 · Cited by 29
Dopaminergic Agents in Rheumatoid Arthritis
Capellino, S. (2019) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-019-09850-5 · Cited by 29
OATP1A2 and OATP2B1 Are Interacting with Dopamine-Receptor Agonists and Antagonists
Schäfer, A. M., zu Schwabedissen, H. E. M., Bien-Möller, S., Hubeny, A., Vogelgesang, S., Oswald, S., & Grube, M. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00159 · Cited by 29
Dopaminergic modulation of reward discounting in healthy rats: a systematic review and meta-analysis
Castrellon, J. J., Meade, J., Greenwald, L. M., Hurst, K., & Samanez-Larkin, G. R. (2020) · Psychopharmacology · doi:10.1007/s00213-020-05723-5 · Cited by 29
Boulghobra, A., Bonose, M., Billault, I., & Pallandre, A. (2022) · Journal of Chromatography B · doi:10.1016/j.jchromb.2022.123264 · Cited by 29
Whole-brain tracking of cocaine and sugar rewards processing
Bijoch, Ł., Klos, J., Pawłowska, M., Wiśniewska, J., Legutko, D., Szachowicz, U., Kaczmarek, L., & Beroun, A. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02318-4 · Cited by 29
Annamneedi, A., Gora, C., Dudas, A., Leray, X., Bozon, V., Crépieux, P., & Pellissier, L. P. (2023) · British Journal of Pharmacology · doi:10.1111/bph.16216 · Cited by 29
Karabacak, Y., Sase, S., Aher, Y. D., Sase, A., Saroja, S. R., Cicvaric, A., Höger, H., Berger, M. L., Bakulev, V. A., Sitte, H. H., et al. (2015) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2015.00215 · Cited by 29
The Dopaminergic Reward System and Leisure Time Exercise Behavior: A Candidate Allele Study
Huppertz, C., Bartels, M., Groen‐Blokhuis, M. M., Dolan, C. V., de Moor, M. H. M., Abdellaoui, A., van Beijsterveldt, C. E. M., Ehli, E. A., Hottenga, J., Willemsen, G. A. H. M., et al. (2014) · BioMed Research International · doi:10.1155/2014/591717 · Cited by 29
Hernández, V. S., Luquı́n, S., Jáuregui-Huerta, F., Corona-Morales, A. A., Medina‐Pizarro, M., Ruiz‐Velasco, S., & Zhang, L. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.11.013 · Cited by 29
Chen, Y., Morganstern, I., Barson, J. R., Hoebel, B. G., & LEIBOWITZ, S. F. (2013) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.12313 · Cited by 29
Involvement of Dopamine D2 Receptors in Addictive-Like Behaviour for Acetaldehyde
Brancato, A., Plescia, F., Marino, R. A. M., Maniaci, G., Navarra, M., & Cannizzaro, C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099454 · Cited by 29
Effects of immobilization stress on emotional behaviors in dopamine D3 receptor knockout mice
Xing, B., Liu, P., Jiang, W., Liu, F., Zhang, H., Cao, G., Chen, T., & Dang, Y. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.01.019 · Cited by 29
Dolinska, J., Chidambaram, A., Adamkiewicz, W., Estili, M., Lisowski, W., Iwan, M., Pałys, B., Sudhölter, E. J. R., Marken, F., Opałło, M., et al. (2016) · Journal of Materials Chemistry B · doi:10.1039/c5tb02175h · Cited by 29
Gholipour, N., Ohradanova‐Repic, A., & Ahangari, G. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26577 · Cited by 29
Cloney, K., Steele, S. L., Stoyek, M. R., Croll, R. P., Smith, F. M., Prykhozhij, S. V., Brown, M. M., Midgen, C., BLAKE, K. D., & Berman, J. N. (2018) · FEBS Journal · doi:10.1111/febs.14473 · Cited by 29
Reinart‐Okugbeni, R., Ausmees, K., Kriis, K., Werner, F. F., Rinken, A., & Kanger, T. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.07.025 · Cited by 29
Dopamine Signaling in Circadian Photoentrainment: Consequences of Desynchrony.
Grippo, R. M., & Güler, A. D. (2019) · PubMed Central · Cited by 29
Adams, R. A., Moutoussis, M., Nour, M. M., Dahoun, T., Lewis, D. J., Illingworth, B. J. G., Veronese, M., Mathys, C. D., de Boer, L., Guitart‐Masip, M., et al. (2019) · Cerebral Cortex · doi:10.1093/cercor/bhz327 · Cited by 29
Lipid Rafts and Dopamine Receptor Signaling
Martinez, V. J., Asico, L. D., José, P. A., & Tiu, A. C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21238909 · Cited by 29
Heteromerization of dopaminergic receptors in the brain: Pharmacological implications
Misganaw, D. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105600 · Cited by 29
Nonhuman Primate Models of Addiction and PET Imaging: Dopamine System Dysregulation
Gould, R. W., Porrino, L. J., & Nader, M. A. (2011) · Current topics in behavioral neurosciences · doi:10.1007/7854_2011_168 · Cited by 29
Clinical Motor and Cognitive Neurobehavioral Relationships in the Basal Ganglia
Leisman, G., Melillo, R. J., & Frederick, R. (2013) · InTech eBooks · doi:10.5772/55227 · Cited by 29
Köhler, J. C., Gröger, N., Lesse, A., Guara Ciurana, S., Rether, K., Fegert, J., Bock, J., & Braun, K. (2019) · Molecular Neurobiology · doi:10.1007/s12035-018-1199-1 · Cited by 28
Guarnieri, L., Bosco, F., Leo, A., Citraro, R., Palma, E., Sarro, G. D., & Mollace, V. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102210 · Cited by 28
Rodgers, E. W., Krenz, W. C., & Baro, D. J. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.2194-11.2011 · Cited by 28
Models of neuromodulation for computational psychiatry
Iglesias, S., Tomiello, S., Schneebeli, M., & Stephan, K. E. (2016) · Wiley Interdisciplinary Reviews Cognitive Science · doi:10.1002/wcs.1420 · Cited by 28
Isoaho, N., Peltola, E., Sainio, S., Koskinen, J., & Laurila, T. T. (2018) · RSC Advances · doi:10.1039/c8ra07766e · Cited by 28
Niewiarowska-Sendo, A., Kozik, A., & Guevara-Lora, I. (2018) · PLoS ONE · doi:10.1371/journal.pone.0206443 · Cited by 28
Martini, M. L., Liu, J., Ray, C., Yu, X., Huang, X., Urs, A. N., Urs, N. M., McCorvy, J. D., Caron, M. G., Roth, B. L., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00351 · Cited by 28
Altered gastric tone and motility response to brain-stem dopamine in a rat model of parkinsonism
Bove, C., Anselmi, L., & Travagli, R. A. (2019) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00076.2019 · Cited by 28
Patel, M. R., Patel, R. B., Thakore, S. D., & Solanki, A. B. (2020) · Pharmaceutical Development and Technology · doi:10.1080/10837450.2020.1772292 · Cited by 28
Anxiety-like behavior in female mice is modulated by STAT3 signaling in midbrain dopamine neurons
Fernandes, M. F., Lau, D., Sharma, S., & Fulton, S. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.04.013 · Cited by 28
Oleson, E. B., Hamilton, L. R., & Gomez, D. M. (2021) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2021.660218 · Cited by 28
Yue, S., Wang, T., Yang, Y., Fan, Y., Zhou, L., Li, M., & Fu, F. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107798 · Cited by 28
Sharifi, A., Karimi‐Haghighi, S., Shabani, R., Asgari, H. R., Ahadi, R., & Haghparast, A. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2021.110458 · Cited by 28
Resistance to Dopamine Agonists in Pituitary Tumors: Molecular Mechanisms
Pivonello, C., Patalano, R., Negri, M., Pirchio, R., Colao, A. A. L., Pivonello, R., & Auriemma, R. S. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.791633 · Cited by 28
González-Usigli, H., Ortíz, G. G., Niño, C. L. C., Mireles-Ramírez, M. A., Pacheco-Moisés, F. P., Torres-Mendoza, B. M., Hernández-Cruz, J. J., Delgado-Lara, D. L. C., & Ramírez-Jirano, L. J. (2023) · Brain Sciences · doi:10.3390/brainsci13030508 · Cited by 28
Schlenker, E. H. (2012) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2012.02.007 · Cited by 28
Santis, M. D., Lian, J., Huang, X., & Deng, C. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115616383 · Cited by 28
Chakroborty, D., Sarkar, C., Lǚ, K., Bhat, M., Dasgupta, P., & Basu, S. (2016) · American Journal Of Pathology · doi:10.1016/j.ajpath.2016.05.008 · Cited by 28
The potential roles of dopamine in malignant glioma
Lan, Y., Wang, X., Xing, J., Lou, J., Ma, X., & Zhang, B. (2016) · Acta Neurologica Belgica · doi:10.1007/s13760-016-0730-2 · Cited by 28
Emerging role of dopamine in neovascularization of pheochromocytoma and paraganglioma
Osinga, T. E., Links, T. P., Dullaart, R. P. F., Pacák, K., van der Horst‐Schrivers, A. N. A., Kerstens, M. N., & Kema, I. P. (2017) · The FASEB Journal · doi:10.1096/fj.201601131r · Cited by 28
Freyberg, Z., & McCarthy, M. J. (2017) · Schizophrenia · doi:10.1038/s41537-017-0018-4 · Cited by 28
Bernosky‐Smith, K. A., Qiu, Y., Feja, M., Lee, Y. B., Loughlin, B., Li, J., & Bass, C. E. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.12.029 · Cited by 28
Lemos, A., Melo, R., Preto, A. J., de Almeida, J. G., Moreira, I. S., & Cordeiro, M. N. D. S. (2018) · Current Neuropharmacology · doi:10.2174/1570159x16666180308161642 · Cited by 28
Orsini, C. A., Hernandez, C. M., Bizon, J. L., & Setlow, B. (2018) · Cognitive Affective & Behavioral Neuroscience · doi:10.3758/s13415-018-00649-0 · Cited by 28
Lee, J., Nam, J. H., Nam, Y., Nam, H. Y., Yoon, G., Ko, E., Kim, G.-C., Bautista, M. R., Capule, C. C., Koyanagi, T., et al. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1321-3 · Cited by 28
Primate Nigrostriatal Dopamine System Regulates Saccadic Response Inhibition
Ogasawara, T., Nejime, M., Takada, M., & Matsumoto, M. (2018) · Neuron · doi:10.1016/j.neuron.2018.10.025 · Cited by 28
de la Mora, M. P., Hernández-Mondragón, J. C., Crespo‐Ramírez, M., Rejón-Orantes, J. D. C., Borroto‐Escuela, D. O., & Fuxé, K. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.07.026 · Cited by 28
Anti‐dopamine D2 receptor antibodies in chronic tic disorders
Addabbo, F., Baglioni, V., Schrag, A. E., Schwarz, M. J., Dietrich, A., Hoekstra, P. J., Martino, D., Buttiglione, M., & Emtics Collaborative Group (2020) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.14613 · Cited by 29
Cosentino, M., Ferrari, M., Kuštrimović, N. Z., Rasini, E., & Marino, F. (2015) · Human Immunology · doi:10.1016/j.humimm.2015.09.032 · Cited by 28
L-745,870 reduces the expression of abnormal involuntary movements in the 6-OHDA-lesioned rat
Huot, P., Johnston, T. H., Koprich, J. B., Espinosa, M. C., Reyes, M. G., Fox, S. H., & Brotchie, J. M. (2014) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000096 · Cited by 28
Mata-Bermúdez, A., Trejo-Chávez, R., Martínez-Vargas, M., Pérez-Arredondo, A., Martínez-Cárdenas, M. D. L. Á., Dı́az-Ruiz, A., Rı́os, C., & Navarro, L. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1447688 · Cited by 27
Identification of a new selective dopamine D4 receptor ligand
Sampson, D., Zhu, X. Y., Eyunni, S., Etukala, J. R., Ofori, E., Bricker, B. A., Lamango, N. S., Setola, V., Roth, B. L., & Ablordeppey, S. Y. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.04.026 · Cited by 27
Pan, B., Huang, X., & Deng, C. (2016) · Scientific Reports · doi:10.1038/srep30040 · Cited by 27
DAKB-GPCRs: An Integrated Computational Platform for Drug Abuse Related GPCRs
Chen, M., Jing, Y., Wang, L., Feng, Z., & Xie, X. (2019) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.8b00623 · Cited by 27
Current Knowledge on the Multifactorial Regulation of Corpora Lutea Lifespan: The Rabbit Model
Zerani, M., Polisca, A., Boiti, C., & Maranesi, M. (2021) · Animals · doi:10.3390/ani11020296 · Cited by 27
de Bartolomeis, A., Ciccarelli, M., Simone, G. D., Mazza, B., Barone, A., & Vellucci, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065945 · Cited by 29
Huang, S.-M., Xiong, M.-Y., Liu, L., Mu, J., Wang, M.-W., Jia, Y., Cai, K., Tie, L., Zhang, C., Cao, S., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2216329120 · Cited by 27
Yu, C., Wang, Z., Han, Y., Liu, Y., Wang, W. E., Chen, C., Wang, H., José, P. A., & Zeng, C. (2014) · Cardiovascular Diabetology · doi:10.1186/1475-2840-13-97 · Cited by 27
Jiang, M., Chen, Y., Li, C., Peng, Q., Fang, M., Liu, W., Qun-zhao, K., Lin, Y., Yung, K. K. L., & Mo, Z. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2016.03.004 · Cited by 27
Xiu, L., Lin, M., Liu, W., Kong, D., Liu, Z., Zhang, Y., Ouyang, P., Liang, Y., Zhong, S., Chen, C., et al. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.0344 · Cited by 27
Neuronal signaling repertoire in the mammalian sperm functionality
Ramírez‐Reveco, A., Villarroel‐Espíndola, F., Rodríguez-Gil, J. E., & Concha, I. I. (2017) · Biology of Reproduction · doi:10.1095/biolreprod.116.144154 · Cited by 27
Rich, M. T., & Torregrossa, M. M. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2017.09.003 · Cited by 27
Metadata
- Authors
- Beaulieu, J.-M., & Gainetdinov, R. R.
- Affiliations
- Université Laval (CA)
- Italian Institute of Technology (IT)
- Venue
- Pharmacological Reviews
- Publisher
- Elsevier BV
- Published
- 2011-03
- Volume
- 63
- Issue
- 1
- Pages
- 182-217
- ISSN
- 0031-6997 (ISSN-L)
- OpenAlex
- W2097744565
- Cited by
- 2,763
- References
- 409
- Citations by year
- 2026: 157 · 2025: 183 · 2024: 172 · 2023: 193 · 2022: 201 · 2021: 197 · 2020: 198 · 2019: 220 · 2018: 200 · 2017: 187 · 2016: 205 · 2015: 175 · 2014: 194 · 2013: 136 · 2012: 101
- FWCI
- 13.93
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Pharmacological Reviews (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Canadian Institutes of Health Research (NSA93798)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- dopamine receptors, dopamine D1/D5 receptors, G protein-coupled receptors, signal transduction, cAMP signaling, G protein-independent signaling, beta-arrestin, receptor desensitization, antiparkinsonian drugs, antipsychotic drugs
- MeSH terms
- Animals, Gene Expression Regulation, Humans, Ligands, Receptors, Dopamine, Signal Transduction, Dopamine Agonists, Dopamine Antagonists, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review